Stock Analysis of Thermogenesis Holdings Inc (THMO) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code THMO
Close 0.555
Change -0.0014 / 0.251 %
Volume 18037.00
Vol Change 4899.00 / 37.29 %
IndustryMedical Devices
SectorHealthcare
AIO Strength Index
Technical StrengthStrong Bearish
Growth Index Low Growth Stock
Value Index No Significant Value
Profitability Index Poor Profitability Stock
Stability Index Poor Stability Stock


Fundamental View of Thermogenesis Holdings Inc


Highs/Lows of Thermogenesis Holdings Inc
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week0.619 10.26 % 0.513 % 0.62480.5429-May-2431-May-24
Two Week0.5869 5.35 % 0.486 % 0.64890.5423-May-2431-May-24
One Month0.6861 19.04 % 4.80 % 0.750.5201-May-2416-May-24
Three Month0.869 36.08 % 3.56 % 0.96980.5208-Apr-2416-May-24
Six Months0.825 32.67 % 15.54 % 1.250.360620-Feb-2425-Jan-24
One year1.3 57.27 % 26.26 % 1.840.360606-Jun-2325-Jan-24
Two year16.515 96.64 % 27.72 % 13.050.360611-Oct-2225-Jan-24
Five year110.25 99.50 % 91.77 % 16.64550.360614-Sep-2225-Jan-24
Ten year15390.0 100.00 % 174.36 % 18359.10.360610-Jun-1425-Jan-24


Technical View of Thermogenesis Holdings Inc






Charts of Thermogenesis Holdings Inc


Returns of Thermogenesis Holdings Inc with Peers
Period / StockTHMOVRAYSINTHSCSARTL
1 Week-10.26%-71.72%10624.85%-11.29%-4.86%
1 Mth-19.04%-93.41%15869.16%-40.48%-0.400%
3 Mth-36.08%-97.83%5165.07%-53.39%-11.04%
6mth-32.67%-99.46%1970.84%-77.27%-0.725%
1 Year-57.27%-99.16%393.20%-94.50%-23.29%
2 Year-96.64%-99.61%-83.52%--72.41%
5 Years-99.50%-99.79%-98.62%--98.96%
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Thermogenesis Holdings Inc with Peers
Ratio / StockTHMOVRAYSINTHSCSARTL
PE-0.090-0.0403-911.09-0.246-0.432
P/B2.390.0440683.810.4560.290
ROA-131.38-41.89-49.22-112.40-63.02
ROE-911.89-109.19-75.05-185.77-67.13
Debt To Equity-4.590.9870.0642.300.0021
Revenue9715.00 K
7.33 %
102206 K
45.76 %
890000
42.99 %
5150.00 K
35731.07 %
0
%
Net Income-14394.00 K
27.72 %
-107330.00 K
2.47 %
-9896.00 K
39.98 %
-6838.79 M
141540 %
-9874.00 K
2.07 %


Technicals of Thermogenesis Holdings Inc with Peers
Technical / StockTHMOVRAYSINTHSCSARTL-
ADX17.9358.9247.7416.0919.83
CMF0.117-0.326-0.388-0.2220.0047
MFI55.825.7164.8557.6242.70
RSI38.2119.9879.7337.1547.35
MACD Abv SignalFalseFalseTrueFalseFalse
Price Above 50 MAFalseFalseTrueFalseFalse-
Price Above 200 MAFalseFalseTrueFalseFalse-


About : Thermogenesis Holdings Inc


Address : 2711 Citrus Road, Rancho Cordova, CA, United States, 95742
Tel : 916 858 5100
URL : https://www.thermogenesis.com
Code : THMO, ISIN : US88362L1008, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 18_Aug_1995
Employee Count : 25

ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for cell-banking, cell-processing, and cell-based therapeutics in the United States, China, the United Arab Emirates, Vietnam, and internationally. The company provides medical device products for automated cell processing. Its clinical bio-banking applications include AXP II Automated Cell Separation System, an automated fully closed cell separation system for isolating stem and progenitor cells from umbilical cord blood; and BioArchive Automated Cryopreservation System, an automated, robotic, liquid nitrogen controlled-rate-freezing and cryogenic storage system for cord blood samples and cell therapeutic products used in clinical applications. The company's point-of-care applications include XP Point-of-Care System, an automated, fully closed, sterile system that allows for the rapid and automated processing of autologous peripheral blood or bone marrow aspirate derived stem cells at the point-of-care, such as surgical centers or clinics; and PXP-1000 System, an automated, fully closed system that provides fast, reproducible separation of multiple cellular components from blood with minimal red blood cell contamination. Its cell processing products comprise X-Series products for general laboratory use, such as X-Lab for cell isolation, X-Wash System for cell washing and reformulation, and X-Mini for high efficiency small scale cell purification. The company also provides contract development and manufacturing services for cell and cell-based gene therapies. It markets and sells its medical device products through independent distributors, as well as direct to end-user customers. The company was formerly known as Cesca Therapeutics Inc. and changed its name to ThermoGenesis Holdings, Inc. in November 2019. ThermoGenesis Holdings, Inc. was incorporated in 1986 and is headquartered in Rancho Cordova, California.


Note : All Data Generated at the End of Trading Hours (EOD Data)